Next Article in Journal
Pseudorabies Virus Glycoproteins E and B Application in Vaccine and Diagnosis Kit Development
Previous Article in Journal
SMS-Based Active Surveillance of Adverse Events following Immunization in Children: The VigiVax Study
Previous Article in Special Issue
A Pseudovirus Nanoparticle Displaying the Vaccinia Virus L1 Protein Elicited High Neutralizing Antibody Titers and Provided Complete Protection to Mice against Mortality Caused by a Vaccinia Virus Challenge
 
 
Article

Article Versions Notes

Vaccines 2024, 12(9), 1077; https://doi.org/10.3390/vaccines12091077
Action Date Notes Link
article xml file uploaded 20 September 2024 11:32 CEST Original file -
article xml uploaded. 20 September 2024 11:32 CEST Update https://www.mdpi.com/2076-393X/12/9/1077/xml
article pdf uploaded. 20 September 2024 11:32 CEST Version of Record https://www.mdpi.com/2076-393X/12/9/1077/pdf
article supplementary file uploaded. 20 September 2024 11:32 CEST - https://www.mdpi.com/2076-393X/12/9/1077#supplementary
article html file updated 20 September 2024 11:34 CEST Original file https://www.mdpi.com/2076-393X/12/9/1077/html
Back to TopTop